骨与软组织上皮样肿瘤鉴别诊断
Antigen Tumor |
KER |
EMA |
MUC4 |
DES |
SMA |
CALD |
S-100P |
HMB-45 |
MART-1 MELAN A |
CD31 |
CD34 |
ERG |
SMARCV1 (INI1)Loss |
EPS |
>95 |
>95 |
0 |
<5 |
33 |
0 |
0 |
0 |
0 |
<1 |
50 |
0 |
95 |
EHE |
30 |
<5 |
0 |
0 |
45 |
0 |
0 |
0 |
0 |
>90 |
50 |
>95 |
0 |
EAS |
>50 |
20 |
0 |
0 |
0 |
0 |
<1 |
0 |
0 |
90 |
50 |
>95 |
0 |
EMPNST |
<5 |
10 |
UNK |
<5 |
<5 |
0 |
>95 |
0 |
0 |
0 |
<10 |
0 |
50 |
CCS |
<1 |
0 |
0 |
0 |
0 |
0 |
>90 |
>90 |
80 |
0 |
<5 |
0(LD) |
0 |
SEF |
<1 |
30 |
80 |
0 |
0 |
0 |
0 |
30 |
0 |
0 |
<1 |
UNK |
UNK |
ELMS |
30 |
30 |
0 |
75 |
85 |
75 |
10 |
0 |
0 |
0 |
15 |
0 |
LD |
ASPS |
0 |
0 |
0 |
10 |
0 |
0 |
<5 |
0 |
0 |
0 |
0 |
0 |
UNK |
PEComa |
0 |
0 |
0 |
70 |
90 |
60 |
10 |
90 |
60 |
0 |
0 |
0 |
UNK |
OS |
20 |
20 |
0 |
<5 |
50 |
0 |
<5 |
0 |
0 |
0 |
10 |
0 |
1 |
MMEL |
<5 |
<5 |
0 |
<10 |
<5 |
0 |
>95 |
80 |
70 |
0 |
0 |
0 |
0 |
MCA |
>95 |
60 |
Variable |
0 |
<5 |
0 |
10 |
0 |
Positive adremal certical carcinema (A103 cleme) |
<1 |
<1 |
Positive in 50% of prostatic adenocareinema |
<1 |
ASPS,软组织腺泡状肉瘤;CCS,透明细胞肉瘤;EAS,上皮样血管肉瘤;EHE,上皮样血管内皮瘤;ELMS,上皮样平滑肌肉瘤;EMPNST,恶性外周神经鞘瘤;EPS,上皮样肉瘤;MCA,转移癌;MMEL,转移性恶性黑色素瘤;OS,骨肉瘤PEComa,血管周上皮细胞肿瘤;SEF,硬化性上皮样纤维肉瘤;LD,limited data。
本手册表格中的英文字母及符号解释:
+:Almost always positive;
N或-:almost always negative;
R:rare positive;
S:sometimes positive;
U:uncertain;
NR:not report;
NK:not known;
NA:not applicable;
ND:尚无文献统计资料
CD34(Endothelial Cell Marker) 内皮细胞标记物
EMA (Epithelial Membrane Antigen) 上皮膜抗原
SMA( Smooth muscle Actin) 平滑肌肌动蛋白
仅供内部参考,欢迎批评指正
版权所有:南京军区南京总医院
技术支持:91360.com